- Kaiser Permanente names SVP, Fresno service area manager
- Nebraska hospital CEO resigns amid allegations of $38K in improper spending
- Northwell’s direct contracting business wants to ‘link up’ with other health systems
- PDS Health among 1st to deploy Epic-integrated AI platform
- CommonSpirit’s 5 targets for judging payer prior auth reform — and its Humana milestone
- LifeBridge names division president
- Private equity struggles in healthcare amid mounting pressures: 5 notes for dentistry
- Who’s actually winning the fight for ASC ownership?
- Why some ASCs are buying their own anesthesia groups
- Hospital Sisters Health System names chief technology officer
- Top Medicare Advantage plans for member satisfaction in 2026: JD Power
- How a 12-hospital system saved millions with an inventory overhaul
- Corporate medicine is burning out 90% of employed physicians: 10 survey findings
- HCA Florida hospital names assistant CFO
- GE HealthCare taps new CFO
- 6-property outpatient portfolio acquired
- Patients deserve every evidence-based option for mental healthcare
- 10 anesthesia controversies in 2026
- The $314K cost of employing a physician
- Who’s driving physician M&A in 2026? 5 deals to know
- 5 ways insurers are undercutting anesthesia payments: ASA
- Prior GLP-1 use doesn’t affect bariatric surgery results: 6 things to know
- Statement on Regulation Crypto Assets: Fit-for-purpose Exemptions for Crypto Market Innovation
- Filling the Regulatory Tank: Regulation Crypto Assets Proposing Release
- Statement on Regulation Crypto Assets
- Dental therapy program enrollment up 533% in 5 years
- Dental assisting program enrollment down 5.2% in 5 years
- Dental hygiene program enrollment up 15% in 5 years
- Surgery Partners ditches its $200M M&A target in favor of de novo growth: 5 things to know
- The dental specialties DSOs will prioritize next
- Statement on Commencement of Appointment Process for Public Company Accounting Oversight Board Seat
- Dental school enrollment in the 10 states with the most dental shortage areas
- How To Protect Yourself During Wildfire Season
- Ballmer Institute lands $125M to expand child behavioral health training nationwide
- Judge weighs whether man charged with killing dentist can act as own attorney
- FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices
- Included Health to offer Carrum specialty care for alternative plan members
- 52 behavioral health executive moves to know
- Hospital performance improves in June, but lags 2025
- University of Toledo gets nearly $2M to support behavioral health workforce
- CTA reporting requirements eliminated for most dental practices: 5 things to know
- National Alliance on Mental Illness names chief medical officer
- Pennsylvania opens 24/7 behavioral health crisis center
- Cyber criminals target DSOs, dental groups: 3 updates
- OpenAI boosts mental health safeguards for teens
- UnitedHealthcare expands behavioral coaching to 13 million members
- Kindergarten Vaccine Exemptions Hit Record High, New CDC Data Shows
- Loneliness Is A Health Crisis, But Doctors Alone Can't Cure It, Analysis Argues
- Ousted OHSU Healthcare CEO files lawsuit alleging wrongful termination, discrimination
- JD Power: Member satisfaction with Medicare Advantage plans continues to slide
- AMA applauds updated CMS prior authorization reporting guidance
- Constipation In Space: A New Study Provides Answers
- Social Media Beauty Trends May Up Teens' Exposure To Hormone-Disrupting Chemicals
- HIPAA-compliant marketing platform Ours Privacy lands $15M amid growing pixel concerns
- Pharma commercialization partner Valeris brings in new strategy chief
- Biokin bispecific ADC iza-bren hits goal in lung cancer trial, boosting case for BMS’ global test
- CSL shares up 17% as immunoglobulin boost points to signs of recovery
- R1 acquiring Humata Health to bolster AI-powered prior authorizations
- Revance hires Janelle Wichmann as chief marketing officer of skincare unit
- CMI adopts orphan drug field with dedicated center of excellence
- Waist Size Is Accurate Way To Gauge Unhealthy Excess Weight, Study Says
- Panel Offers First Guidelines For Using E-Cigarettes To Help Smokers Quit
- Celcuity keeps cool amid questions about Revtorpyk launch timing
- Newsom Promotes Affordable Insulin, But California's Generic Label Off To A Slow Start
- What Geriatric Emergency Departments Do Differently
- Drive for Nuclear Power Boosts Uranium Industry — And Tribal Health Concerns in Southwest
- Rural primary care company Hopscotch clinches $53M to expand beyond NC
- Eurofins expands operations to meet growing high-potency API demand
- 24 new behavioral health projects to know
- Four health systems, including Ochsner and Denver Health, go live with Epic's real-time prior authorization checks
- 8 new psychiatric residency programs to know
- DocGo agrees to acquire virtual care provider Hicuity Health, assumes $52M debt
- Papa, eternalHealth expand partnership around Plus platform
- Happy Health secures $75M to expand AI-powered care in the home starting with sleep apnea
- As healthcare costs weigh on patients, states could play a bigger role, report finds
- Jalapeño Recalls Keep Growing As Salmonella Outbreak Investigation Continues
- Music Streaming Linked To Rise In Traffic Deaths
- EyePoint shares plummet after phase 3 stumble for AMD drug-device combo Duravyu
- Quanovate takes back marketing claims for Mira fertility wand after P&G challenge
- Sanofi to lay off 229 Blueprint Medicines staffers, close Cambridge offices following acquisition
- Whoop expands Advanced Labs to non-members, adds Grail’s multi-cancer detection test to lineup
- Quartz Countertop Workers Are Falling Prey To Lung Disease
- Kaiser Permanente notches 4.6% Q2 operating margin, $5.3B net income
- Epic faces Federal Trade Commission antitrust investigation, Reuters reports
- Innovaccer, Mastek ink strategic partnership to scale agentic AI in healthcare globally
- Sandoz strikes $322M biosimilars deal with Shanghai Henlius
- Argenx heads to FDA with Vyvgart after ph. 3 win in potential blockbuster autoimmune indication
- Many Smokers Unaware Of Heart, Brain Risks Of Smoking
- Tylenol, Other Medications Fuel Spike In Liver Damage Cases, Poison Center Data Says
- AstraZeneca touts Enhertu, Orpathys dual lung cancer wins amid bispecific failure
- My Husband Was Kicked Out Of Hospice For Dying Too Slowly
- Tadalafil (Cialis), Used for BPH and ED, Might Increase Glaucoma Risk, Study Says
- Kennedy’s Quiet Hunt for Autism Culprits Stalls as Trump Orders Baseless Changes to Childhood Shots
- Newsom Promotes Affordable Insulin, but California’s Generic Label Off to a Slow Start
- Inside agency view: Real Chemistry’s Frank Mazzola on audience nuance and rewarding creativity
- Abridge expands AI decision support to more clinicians in bid to become healthcare's copilot
- Danish politicians call out Eli Lilly obesity campaign
- Universal Health Services closes $835M Talkspace acquisition
- Gounder Brings Clarity to Egg Freezing, AI Virus Creation, and New Trump Vaccine Order
- States Enact Emergency Orders On Kratom While Awaiting Federal Rules
- Study examines how ICHRA adoption could help stabilize ACA risk pools
- Winter Is Coming: How Vaccines Help Protect Against Respiratory Illness
- Screen Time Is Not All Bad For Kids' Brains
- Processed Foods Linked To Prostate Cancer Risk
- Updated Statement Regarding the Division of Corporation Finance’s Role in the Exchange Act Rule 14a-8 Process
- It's BMS vs. Celgene investors once more after US appeals court revives lawsuit
- Industry Voices—AI should help cancer patients survive the healthcare system
- Tavneos trial flagged for 'serious breaches' of protocol as EU regulators dissect market withdrawal decision
- Sleep Disturbances Linked To Genetic Alzheimer's Risk
- Pre-K Sets Kids Up For School Success, Study Says
- Expect Other Seniors To Act Their Age? Then Expect Problems With Your Own Memory, Study Says
- A genomics library for the AI era
- BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nod
- People With Disabilities Say Medicaid Income Limits Stifle Career Advancement
- Trump Team’s Use of Arcane Budget Rule Threatens Medicaid Coverage
- My Husband Was Kicked Out of Hospice for Dying Too Slowly
- Fierce Pharma Asia—Legend’s first profit; Taiho, Cullinan’s EGFR win; WuXi AppTec’s reprieve
- Rare Bacteria In Coastal Waters Has Killed 7 This Summer
- It's crunch time for Karyopharm as company faces potential default next month
- Socializing: A Prescription For Healthier Brain Aging
- Taking The Stairs May Lower Your Risk Of Dying From Heart Disease
- AZ's blood pressure newcomer Baxfendy fails to meet cost-effectiveness bar, ICER says
- How consumerization is reshaping pharma marketing
- Sweet Tooth? It Could Be Shaping Your Decisions, Study Says
- Stressed Parents Turn To Screens For Help, Study Finds
- Gambling Linked To Mental Health Problems Among College Students
- Hospitals Say They Found A Tool To Help Reduce Childbirth Risks: Wristbands
- Listen to the Latest ‘KFF Health News Minute’
- Readers Speak Out on Work Requirements, Federal Data Grab, Opioid Payback Cash
- People With Disabilities Say Medicaid’s Limits on Income Stifle Career Advancement
- FDA Wants More Information From Food Makers On New Food Chemicals
- Aspirin/Omega-3 Combo Matches Antibiotics In Treating Gum Disease, Trial Finds
- Endometriosis Linked To Higher Type 2 Diabetes Risk
- Beyond Compliance: Rethinking No Surprises Act strategy
- Tamiflu Helps Keep Severely Ill Kids Out Of The ICU, Study Finds
- 'Normal' Can Backfire During Doctor/Patient Discussions
- Experimental Pulse Oximeter Accurate Regardless Of Skin Tone, Researchers Say
- Patients Wary Of Governments, Companies Pushing AI As A Rural Healthcare Solution
- Executive Order Calls For Fewer Routine Childhood Vaccines, Doctors Push Back
- Real-World Performance Of Alzheimer's Drug, Leqembi, Matches Trial Data, Study Finds
- Study Finds Undisclosed Chemicals In Most Personal Care Products
- Chairman Paul S. Atkins Letter to Robert Walley, Chair, CAT NMS Plan Operating Committee
- What 524B and QMSR Change About Medical Device Risk
- Taking Lean Manufacturing to the Next Level
- Why Few MedTech Sales Teams Are Using AI Where It Matters Most
- Why Organizations Miss Emerging Product Risk: Understanding the engineering mechanisms that remain hidden long before complaint trends become visible
- Update on the SEC’s Work Toward Treasury Clearing Implementation [August 2026]
- The Interface is the Risk: A MedTech Blueprint for AI and System Integration
- Restoring Regulatory Clarity: Statement on Technical Amendments to Rule 0‑1(a)(7)
- Beyond the Status Report: Using LLMs to Reveal the True State of SaMD Development
Michigan healthcare freedom community forum
The charges since 2019 included over 5,500 surgeries and 8,500 courses of hormones or puberty blockers, according to a new report commissioned by the Department of Health and Human Services (HHS). The report is titled: Wolves in White Coats: How Doctors and Hospitals Pushed and Profited from the Fraud of “Gender Medicine".
Some providers used misleading or potentially fraudulent billing codes to get insurers to cover the interventions, according to HHS. The department identified nearly $ 50 million in claims for puberty blockers given to children aged nine to 17 under a general hormone-disorder code without a gender-related or early-puberty diagnosis on the same claim.
Hospitals and clinics identified in the report have been referred to the Department of Justice and investigators from the Department of Health and Human Services (HHS) for potential violations of federal law. According to HHS, the observed billing patterns require additional investigation.
Another $ 11 million was billed for puberty blockers for hundreds of patients aged 13 to 17 under a diagnosis for unusually early puberty. HHS said that this diagnosis does not apply at those ages.
The report said the procedures offered hospitals a long-term source of revenue, as minors who begin hormone drugs can remain in medical care for years. Citing outside estimates, it put lifetime costs at up to $ 75,000 without surgery and as much as $ 170,000 when operations are included.
Here is the HHS Executive Summary of this 64 page report:
https://www.hhs.gov/sites/default/files/hhs-wolves-white-coats-executive-summary.pdf
https://www.hhs.gov/sites/default/files/hhs-wolves-in-white-coats.pdf
Wolves in White Coats: How Doctors and Hospitals Pushed and Profited from the Fraud of “Gender Medicine”
A report commissioned by the U.S. Department of Health and Human ServicesEXECUTIVE SUMMARY
In the 2010s, financial incentives contributed to the rapid expansion of pediatric gender clinics and programs by creating long-term revenue opportunities for these medical establishments. Unlike most traditional pediatric services, which involve episodic or short‑term care, children receiving puberty blockers, cross-sex hormones, surgeries, and related services may require recurring endocrinology visits, laboratory monitoring, prescriptions, mental‑health services, surgical procedures, and follow‑up care extending into adulthood. This pediatric medical field effectively creates “captive patients.”
All‑payer claims and cost data indicate nearly $120 million in billed charges for sex‑rejecting procedures involving minors since 2019. These charges include more than 5,500 surgical procedures and 8,500 courses of hormones or puberty blockers. The analysis concludes that these continuing interventions have created financially valuable patient populations for hospitals and associated specialties.
- Cross-sex hormone therapy entails average yearly payer costs per patient ranging between $545 (androgens), $735 (estrogens), and $16,385 (for the more costly puberty-blocker GnRH). Surgical interventions, such as mastectomies, mammoplasties, and phalloplasties, can range from $12,000 to over $130,000.
Potentially Fraudulent Medical Coding
An analysis of the data suggests that some providers may have used diagnosis codes that did not accurately reflect patients' underlying conditions in order to obtain insurance coverage for sexrejecting procedures, particularly with ICD-10 code E34.9 (“endocrine disorder, unspecified”) and the ICD-10 codes for central “precocious puberty.”
- Between 2015 – 2025, public and private insurance was billed nearly $50 million for puberty blocking drugs in patients aged 9-17 with Endocrine Disorder diagnoses (excluding precocious puberty, the typical indication for puberty blockers).
- During this same timeframe, nearly $11 million was billed for puberty blockers, including to Medicaid and Medicare, for hundreds of patients between the age of 13 and 17 with a diagnostic code for precious puberty. By definition, anyone 13 or older cannot have a diagnosis of precocious puberty and should not be given puberty blockers at that age for this indication
Federal Policy and Institutional Pressure
The Biden Administration, particularly HHS, under the leadership of Secretary Becerra and Admiral Levine, contributed to the expansion and normalization of sex-rejecting interventions through nondiscrimination policies, insurance requirements, agency guidance, litigation positions, federal employee benefits, and other federal programs.
Influence of Professional Medical Organizations
Organizations like World Professional Association for Transgender Health, the Endocrine Society, the American Psychological Association, and the American Academy of Pediatrics contributed to the promotion of pediatric sex-rejecting interventions, even while undercutting their own evidence base. This professional network created an institutional environment in which sex-rejecting medical interventions became increasingly accepted, while opposing clinical perspectives, uncertainties, and potential risks that caused irreversible damage received insufficient consideration.
Patient and Parent Experiences
Eight first-hand testimonies from patients and parents illustrate weakness in clinical safeguards and informed-consent processes. Common themes include distress related to a child’s sex and rapid medical interventions, insufficient examination of underlying psychological, developmental, social, or trauma-related factors, limited discussion of irreversible damage, pressure placed on parents to
approve “treatment,” adverse physical and psychological outcomes, and difficulty obtaining appropriate medical care after stopping treatment or detransitioning. These testimonies underscore the imbalance between the structured healthcare pathways available for initiating medical transition and the comparatively limited clinical infrastructure available to patients seeking to discontinue treatment, address complications, or detransition.Conclusion
The expansion of pediatric sex-rejecting procedures resulted from an interaction among financial incentives, potentially illegal billing practices, ideological and professional influences, federal policy, and inadequate oversight. The medical establishment and the government failed innocent children. This report exposes how these calculated financial and political efforts left children irreversibly harmed and abandoned at the very moments when they needed real support.
Vice President J.D. Vance and Health and Human Services Secretary Robert F. Kennedy Jr. have now referred hospitals and gender clinics identified in the HHS report titled: Wolves in White Coats: How Doctors and Hospitals Pushed and Profited from the Fraud of “Gender Medicine" to Attorney General Blanche for prosecution:
Vance, Kennedy refer gender clinics for prosecution based on HHS billing fraud probe
If flagged providers were "intentionally" miscoding treatment to "secure insurance coverage for gender-transitioning interventions that insurance would not otherwise cover," Vance says "they should go to prison."
By Greg Piper - August 13, 2026A day after the Trump administration ended federal funding of "sex-rejecting procedures on children," otherwise known as gender affirming care, Vice President J.D. Vance and Health and Human Services Secretary Robert F. Kennedy Jr. referred hospitals and gender clinics identified in a new HHS billing fraud report for prosecution and investigation.
Vance's letter to Attorney General Todd Blanche asks the Justice Department to investigate whether flagged providers violated the Food, Drug, and Cosmetic Act, False Claims Act and federal fraud and conspiracy laws by "intentionally" miscoding treatment to "secure insurance coverage for gender-transitioning interventions that insurance would not otherwise cover." If so, "they should go to prison."
"More than just pushing these procedures on kids, hospitals and providers may have been defrauding Medicaid and private insurers by using misleading or fraudulent billing codes to get insurance to cover the costs," Vance said in an X thread on the report and criminal referral.
Kennedy's letter to HHS Inspector General T. March Bell asks him to review "an objectively defined cohort of claims that exhibit potentially anomalous billing patterns" by hundreds of flagged providers in the HHS report, which may violate federal law.
The secretary's letter identifies four fishy cohorts: claims for puberty blockers with endocrine disorder diagnosis on the same claim with "no gender diagnosis" and "no precocious puberty" diagnosis, ages 9-17; claims for puberty blockers with precocious puberty diagnosis, 13-17; claims for "primary gender dysphoria" diagnosis with a cross-sex hormone prescription "written the same day" in a state where that's prohibited for minors, 17 and younger; and affiliates to whom prescribers billed at least 95% of their claims in a prescription year and are registered at one of their addresses, all of them Planned Parenthood clinics.
One of the original Texas whistleblowers sees the hospital who fired her do a 180.
https://www.dailysignal.com/2026/08/14/sivadge-story-detransition-clinic/
Vanessa Sivadge Shares the Story Behind America’s First-Ever Detransition Clinic
Emma Dayton | August 14, 2026
In a historic $10 million settlement, Texas Children’s Hospital agreed to open the nation’s first-ever detransition clinic by October and fire five physicians after the hospital allegedly funded gender-transition procedures using Texas Medicaid.
Vanessa Sivadge, the whistleblower who sounded the alarm in May 2023, explained that working as a nurse at Texas Children’s Hospital was a dream come true.
“I thought I had peaked in my career,” Sivadge said during an appearance before grassroots leaders at Heritage Action’s Southwest Sentinel Summit in Phoenix this month.
“I thought this was going to be my dream job where I would be for the rest of my life,” she said.
Sivadge recalled watching Texas Children’s Hospital “sell a lie” to struggling children and make them “a slave to the pharmaceutical industry for life” through permanent gender-transition procedures.
“They were promised that on the other side of medical transition, that they would find fulfillment and happiness and peace,” Sivadge said. “That is the lie of the gender medicine industry. It convinces and exploits children to believe that they were born into the wrong body, that they are not fearfully and wonderfully made, and that their confusion will resolve on the other side of a drug or a surgery.”
Sivadge told the crowd of grassroots leaders that this spiritual attack on God’s design of “male and female” eventually forced her to expose the “darkness.”
“So, with a lot of fear and with a lot of tears and a lot of uncertainty, I called a journalist in May of 2023,” Sivadge said. “That is when, anonymously, I blew the whistle against the secret transgender medicine program that Texas Children’s Hospital was conducting.”
While she thought no one knew her identity, Sivadge was shocked when two agents from the Biden-Harris Federal Bureau of Investigation knocked on the front door of her home. Sivadge explained that the FBI agents proceeded to intimidate and threaten her to remain silent about the alleged Medicaid fraud.
Yet what she characterized as a scare tactic had the opposite of its intended effect.
“I often say now that if the FBI hadn’t come to our home and hadn’t threatened my career, my safety, I don’t think that I would have been as emboldened as I was to do what happened next,” Sivadge said.
Sivadge came forward publicly in June 2024 after seeing three ways the hospital was allegedly committing fraud: failing to list the biological sex on claims; using false diagnoses to receive reimbursements; and filing for Medicaid when Texas clearly forbids taxpayer-funded gender procedures.
Texas Children’s Hospital fired Sivadge two months later, and the nurse was unable to find other employment after the hospital began making public statements. Sivadge finally found an ally in President Donald Trump when he assumed office in 2025. One week after she testified in a congressional hearing on ending lawfare toward whistleblowers who protect children, the Department of Health and Human Services launched a formal investigation.
“The most important and the most profound action that was taken was that they opened a whistleblower tip line for the first time ever, where they invited the public to submit tips on this publicly accessible tip line under HHS,” Sivadge said.
She believes the new detransition clinic will provide hope to those who are victims of gender procedures.
“This will be the first clinic of its kind where not just victims from Texas, but victims from America, victims from all over the world will be able to come and get free mental and medical care for the first five years,” Sivadge said.
Sivadge is now the president of Protecting Texas Children, an organization she founded to advocate for Texas children to “fulfill their God-given potential.” She continues to speak up on the realities of “radical gender ideologies” and encourages others to advocate for the rights of children.
“My advocacy has just changed addresses,” Sivadge said. “Before it was in the hospital, and now it’s in the capital.”
“Each one of you has an opportunity to expose darkness and to embrace what is right and good and beautiful and true,” Sivadge said. “And so, that would be my encouragement to each of you, is to choose courage.”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.























